Companies / Communication Services
NFLX
Netflix
Movies & Entertainment
Movies & EntertainmentAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health79
Growth73
Profitability85
Cash generation77
Balance sheet75
Dilution control86
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)11.8%Revenue growth (FY)15.9%Revenue CAGR (3y)12.6%Gross margin48.5%Operating margin29.5%Net margin24.3%Free cash flow margin20.9%R&D / revenue7.5%Stock comp / revenue0.8%Net debt / operating cash flow0.53xCurrent ratio1.19Diluted share count change-1.1%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $29.7B | $31.6B | $33.7B | $39.0B | $45.2B |
| Gross profit | $12.4B | $12.4B | $14.0B | $18.0B | $21.9B |
| Operating income | $6.2B | $5.6B | $7.0B | $10.4B | $13.3B |
| Net income | $5.1B | $4.5B | $5.4B | $8.7B | $11.0B |
| Operating cash flow | $393M | $2.0B | $7.3B | $7.4B | $10.1B |
| Capital expenditure | $525M | $408M | $349M | $440M | $688M |
| Free cash flow | -$132M | $1.6B | $6.9B | $6.9B | $9.5B |
| R&D | $2.3B | $2.7B | $2.7B | $2.9B | $3.4B |
| Stock-based comp | $403M | $575M | $339M | $273M | $368M |
| Buybacks | $600M | $0 | $6.0B | $6.3B | $9.1B |
| Cash | $6.0B | $5.1B | $7.1B | $7.8B | $9.0B |
| Total debt | $15.4B | $14.4B | $14.5B | $15.6B | $14.5B |
| Equity | $15.8B | $20.8B | $20.6B | $24.7B | $26.6B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.